| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1078-0432.CCR-04-2670 |
| P8608 | Fatcat ID | release_gbcb53cj4rhfxaldk4iix2zoge |
| P698 | PubMed publication ID | 16144912 |
| P50 | author | Tanri Shiozawa | Q115215703 |
| P2093 | author name string | Ikuo Konishi | |
| Hiroyasu Kashima | |||
| Tsutomu Miyamoto | |||
| Akihisa Suzuki | |||
| Miyuki Kurai | |||
| Yu-Zhen Feng | |||
| P2860 | cites work | Mutations of the BRAF gene in human cancer | Q27860760 |
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endometrial carcinoma | Q18555222 |
| DNA mismatch repair | Q2984243 | ||
| P304 | page(s) | 6133-6138 | |
| P577 | publication date | 2005-09-01 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | BRAF mutation in endometrial carcinoma and hyperplasia: correlation with KRAS and p53 mutations and mismatch repair protein expression | |
| P478 | volume | 11 |
| Q36815539 | BRAF V600 mutations in Langerhans cell histiocytosis with a simple and unique assay |
| Q54452740 | BRAF V600E Mutations in Endometrial Adenocarcinoma |
| Q37988572 | BRAFmutation testing in clinical practice |
| Q33738168 | Current and emerging trends in Lynch syndrome identification in women with endometrial cancer. |
| Q57048318 | DNA Repair Gene (XPD, XRCC4, and XRCC1) Polymorphisms in Patients with Endometrial Hyperplasia: A Pilot Study |
| Q33861173 | Development, characterization, and reversal of acquired resistance to the MEK1 inhibitor selumetinib (AZD6244) in an in vivo model of childhood astrocytoma |
| Q36410067 | Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment |
| Q38123671 | Endometrial tumour BRAF mutations and MLH1 promoter methylation as predictors of germline mismatch repair gene mutation status: a literature review |
| Q33781274 | Genetics of endometrial cancers |
| Q37432375 | Genomic characterization of gene copy-number aberrations in endometrial carcinoma cell lines derived from endometrioid-type endometrial adenocarcinoma |
| Q44394416 | Germline mutation in BRAF codon 600 is compatible with human development: de novo p.V600G mutation identified in a patient with CFC syndrome |
| Q42223250 | Long non-coding RNA TUG1 promotes endometrial cancer development via inhibiting miR-299 and miR-34a-5p |
| Q35073876 | Low mutational burden of eight genes involved in the MAPK/ERK, PI3K/AKT, and GNAQ/11 pathways in female genital tract primary melanomas. |
| Q51135997 | Molecular profiles of benign and (pre)malignant endometrial lesions |
| Q37959376 | New insights in endometrial carcinogenesis. |
| Q41136357 | Non-invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patients |
| Q36351953 | Oncodomains: A protein domain-centric framework for analyzing rare variants in tumor samples |
| Q54468512 | Oncogene alterations in endometrial carcinosarcomas |
| Q80209882 | PIK3CA mutations in the kinase domain (exon 20) of uterine endometrial adenocarcinomas are associated with adverse prognostic parameters |
| Q54532022 | Prospective evaluation of molecular screening for Lynch syndrome in patients with endometrial cancer ≤ 70 years |
| Q37113899 | Proteomics identification of cyclophilin a as a potential prognostic factor and therapeutic target in endometrial carcinoma |
| Q54308255 | Rectal cancer profiling identifies distinct subtypes in India based on age at onset, genetic, epigenetic and clinicopathological characteristics. |
| Q39709021 | Spectrum of KIT/PDGFRA/BRAF mutations and Phosphatidylinositol-3-Kinase pathway gene alterations in gastrointestinal stromal tumors (GIST) |
| Q36151896 | The genomics and genetics of endometrial cancer |
| Q26779980 | Tumor progression, metastasis, and modulators of epithelial-mesenchymal transition in endometrioid endometrial carcinoma: an update |
| Q33526301 | Two multiplex assays that simultaneously identify 22 possible mutation sites in the KRAS, BRAF, NRAS and PIK3CA genes |
Search more.